Reduced Antibacterial Drug Resistance and

Aging Amoxicillin / pharmacology Animals Anti-Bacterial Agents / pharmacology Cattle Cattle Diseases / microbiology Ciprofloxacin / pharmacology Drug Resistance, Bacterial Escherichia coli / drug effects Escherichia coli Infections / microbiology Farms Feces / microbiology Streptomycin / pharmacology Temperature Tetracycline / pharmacology beta-Lactamases / genetics
antibiotic resistance food-borne pathogens mathematical modeling surveillance studies

Journal

Applied and environmental microbiology
ISSN: 1098-5336
Titre abrégé: Appl Environ Microbiol
Pays: United States
ID NLM: 7605801

Informations de publication

Date de publication:
26 02 2021
Historique:
received: 20 06 2020
accepted: 17 12 2020
pubmed: 6 1 2021
medline: 7 4 2021
entrez: 5 1 2021
Statut: epublish

Résumé

Little is known about the drivers of critically important antibacterial resistance in species with zoonotic potential present on farms (e.g., CTX-M β-lactamase-positive

Identifiants

DOI: 10.1128/AEM.01468-20 PMID: 33397699 PMC: PMC8105006
pubmed: 33397699
pii: AEM.01468-20
doi: 10.1128/AEM.01468-20
pmc: PMC8105006
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Ciprofloxacin 5E8K9I0O4U
Amoxicillin 804826J2HU
beta-Lactamases EC 3.5.2.6
Tetracycline F8VB5M810T
Streptomycin Y45QSO73OB

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 American Society for Microbiology.

Références

J Antimicrob Chemother. 2006 Jan;57(1):154-5
pubmed: 16284100
J Antimicrob Chemother. 2017 Aug 1;72(8):2145-2155
pubmed: 28541467
Res Vet Sci. 2016 Dec;109:107-113
pubmed: 27892858
Appl Environ Microbiol. 2012 Jul;78(13):4552-60
pubmed: 22544245
J Dairy Sci. 2014 Dec;97(12):7644-54
pubmed: 25306279
Sci Rep. 2019 Jan 24;9(1):443
pubmed: 30679480
J Antimicrob Chemother. 2012 Mar;67(3):582-8
pubmed: 22207594
J Antimicrob Chemother. 2011 Jan;66(1):86-95
pubmed: 21098542
Emerg Infect Dis. 2011 Jul;17(7):1216-22
pubmed: 21762575
Prev Vet Med. 2014 Nov 15;117(2):403-12
pubmed: 25172121
J Antimicrob Chemother. 2012 Jul;67(7):1769-74
pubmed: 22514260
Nat Clim Chang. 2018 Jun;8(6):510-514
pubmed: 30369964
J Antimicrob Chemother. 2012 Nov;67(11):2631-4
pubmed: 22868643
Biomed Environ Sci. 2016 May;29(5):374-8
pubmed: 27353712
BMC Microbiol. 2019 Sep 12;19(1):217
pubmed: 31514734
Appl Environ Microbiol. 2016 Jun 13;82(13):3765-3773
pubmed: 27084013
Prev Vet Med. 2012 Oct 1;106(3-4):225-34
pubmed: 22552330
J Antimicrob Chemother. 2020 Jan 1;75(1):65-71
pubmed: 31538190
J Dairy Sci. 2017 Dec;100(12):9667-9673
pubmed: 28987573
Drugs. 2019 Sep;79(14):1529-1541
pubmed: 31407238
Clin Infect Dis. 2015 Feb 1;60(3):439-52
pubmed: 25301206
J Dairy Sci. 2018 Aug;101(8):7540-7550
pubmed: 29859692
J Antimicrob Chemother. 2018 May 1;73(5):1368-1388
pubmed: 29514211
Plasmid. 2018 Sep;99:72-81
pubmed: 30194944
Vet Microbiol. 2012 Jan 27;154(3-4):339-46
pubmed: 21840142
J Antimicrob Chemother. 2020 Sep 1;75(9):2471-2479
pubmed: 32542329
Drugs. 2012 Jan 1;72(1):1-16
pubmed: 22191792
J Clin Microbiol. 2001 May;39(5):1845-9
pubmed: 11326001

Auteurs

Hannah Schubert (H)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

Katy Morley (K)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

Emma F Puddy (EF)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.
School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.

Robert Arbon (R)

Jean Golding Institute, University of Bristol, Bristol, United Kingdom.

Jacqueline Findlay (J)

School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.

Oliver Mounsey (O)

School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.

Virginia C Gould (VC)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.
School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.

Lucy Vass (L)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.
Bristol Population Health Science Institute, University of Bristol, Bristol, United Kingdom.

Madeleine Evans (M)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

Gwen M Rees (GM)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

David C Barrett (DC)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

Katy M Turner (KM)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

Tristan A Cogan (TA)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

Matthew B Avison (MB)

School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom bimba@bristol.ac.uk.
ORCID: 0000-0003-1454-8440

Kristen K Reyher (KK)

Bristol Veterinary School, University of Bristol, Bristol, United Kingdom.

Articles similaires

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male

Evaluating the efficacy of telesurgery with dual console SSI Mantra Surgical Robotic System: experiment on animal model and clinical trials.

Sudhir Prem Srivastava, Vishwajyoti Pascual Srivastava, Avinesh Singh et al.
1.00
Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell

FBXO22 inhibits colitis and colorectal carcinogenesis by regulating the degradation of the S2448-phosphorylated form of mTOR.

Minle Li, Xuan Chen, Pengfei Qu et al.
1.00
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice

Classifications MeSH

questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Vieillissement › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › bêta-Lactames › Pénicillines › Benzylpénicilline › Ampicilline › Amoxicilline › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Eucaryotes › Animaux › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antibactériens › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Artiodactyla › Ruminants › Bovins › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Maladies de l'animal › Maladies des bovins › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Composés hétérocycliques › Composés hétérocycliques à cycles fusionnés › Composés hétérobicycliques › Quinoléines › Quinolinone › Fluoroquinolones › Ciprofloxacine › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance bactérienne aux médicaments › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Bactéries › Proteobacteria › Gammaproteobacteria › Enterobacteriaceae › Escherichia › Escherichia coli › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Infections bactériennes › Infections bactériennes à Gram négatif › Infections à Enterobacteriaceae › Infections à Escherichia coli › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Établissements non médicaux publics ou privés › Installations industrielles et de fabrication › Fermes › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Liquides et sécrétions biologiques › Fèces › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Glucides › Hétérosides › Aminosides › Streptomycine › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Environnement et santé publique › Environnement › Concepts météorologiques › Atmosphère › Temps (météorologie) › Température › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Composés polycycliques › Hydrocarbures aromatiques polycycliques › Naphtacènes › Tétracyclines › Tétracycline › Reduced Antibacterial Drug Resistance and
questionsmedicales.fr › Enzymes et coenzymes › Enzymes › Hydrolases › Amidohydrolases › bêta-Lactamases › Reduced Antibacterial Drug Resistance and